Mesoblast (MESO) - NASDAQ
From other sites
Company Description
Mesoblast Ltd. engages in the development of bio-therapeutics based on its proprietary cell-based and protein technologies. Its proprietary cell-based core technologies include highly purified, immunoselected Mesenchymal Precursor Cells (MPCs), culture-expanded Mesenchymal Stem Cells (MSCs),... More
Sector: Healthcare
Industry: Biotechnology
Country: Australia